DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Wischik CM, Staff RT, Wischik DJ. , et al.
Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease.
J Alzheimers Dis 2015;
44 (02) 705-720
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.